This blog will continue to follow Jakes progress through physical therapy and rehabilitation while also following the successes of other patients and trying to give more information about this new promising treatment. Below is a FAQ written by Dr. RV Kumar inventor of the Cytotron. It is quite informative and explains Cytotron technology as it is being used regeneratively to promote cartilage growth in knees as an alternative to knee replacement and degeneratively to stop cancer.
Click on the link:
http://www.intelligentsolutions.tv/cytotron/answersfromdrkumar.pdf
2 comments:
I have a question for Dr Sibia
I want to thank you for the wonderful work you are doing. Your name will stay for ever in my heart.
After reading "answers from dr Kumar" on the blog, I am very confused by the fact that the Cytotron Centers are licensed only for treating “terminal” cancer patients. Does this means a patient has to go through all the destructive chemo-radiations or surgical treatments before he or she can be eligible for treatments with Cytotron?
If it is the case, the statistical survival rates are really against a lot of cancer patients and I do not see why one would wait and subject oneself to barbaric and cruel treatments and would risk the spreading of cancer cells in other part of the body before coming to see you. Yes, some small localized tumors are treatable the conventional way but they are more the exceptions than the normal and lets face it, by definition, most of the cancers are terminal.
So my question is, in view of all the positive results from the Cytotron, why and who limits you with such a license and when do you think this will change?
My husband John and myself are long time friends and business partners with Dr. Kumar, working on bringing the Cytotron to North and South American and Canadian markets. As a cancer biologist with 25+ years in cancer research, and a co-founder of a pharmaceutical company that develops drugs that target only cancer cells, I would like to address your question and explain how the process of approval for medical devices/drugs works. Conventionally, any investigational new drug or device has to be tested in clinical trials in various Phases. The Phase I drug trial is generally a safety study to determine the maximum tolerated dose in man. The drug then has to go through a Phase II, III prior to approval for commercial use. Phase I cancer drug /device trials are commonly done in patients who have undergone conventional treatment and are fit enough to receive the new drug, based on certain inclusion/exclusion criteria. In the case of the Phase I trial with th Cytotron, it too had to be done with patients who were terminally ill and had no other alternative treatment options available. These patients too saw some benefit and that is why such patients are being treated with the device currently till regulatory approval for the device is obtained. A randomized Phase II study has now been initiated in India to include patients who will receive the Cytotron treatment before they go on to receive conventional standard of care treatment options.It will be good to see how these patients will benefit in the long term and only then will this treatment be approved for primary cancers as well.
Please feel free to contact me should you have any further questions.
_____________________________-
Prof. Meena Augustus PhD.
Exec VP and CSO
Shreis Scalene Sciences LLC.
www.shreis.com
Federal Contractor-NCI Nanotechnology Initiative
CanCure Consulting LLC.
&
Executive Partner,
Health Care Global Enterprises Ltd.
& Triesta Sciences Inc.
USA/Bangalore, India
www.hcgoncology.com
email: maugustus@shreis.com
Post a Comment